BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $256,000 | -32.8% | 23,900 | +1.9% | 0.34% | +31.8% |
| Q1 2022 | $381,000 | +12.1% | 23,450 | -7.5% | 0.26% | +183.7% |
| Q4 2021 | $340,000 | +6.9% | 25,359 | +7.0% | 0.09% | +2.2% |
| Q3 2021 | $318,000 | -19.5% | 23,700 | -1.5% | 0.09% | -43.8% |
| Q2 2021 | $395,000 | +51.9% | 24,050 | 0.0% | 0.16% | +97.5% |
| Q1 2021 | $260,000 | +46.9% | 24,050 | +1.1% | 0.08% | +6.6% |
| Q4 2020 | $177,000 | +98.9% | 23,800 | -4.0% | 0.08% | +90.0% |
| Q3 2020 | $89,000 | -1.1% | 24,800 | +30.9% | 0.04% | +5.3% |
| Q2 2020 | $90,000 | +143.2% | 18,950 | 0.0% | 0.04% | +137.5% |
| Q1 2020 | $37,000 | -30.2% | 18,950 | 0.0% | 0.02% | -23.8% |
| Q3 2019 | $53,000 | -76.2% | 18,950 | -30.9% | 0.02% | -85.4% |
| Q1 2019 | $223,000 | -11.2% | 27,443 | -4.4% | 0.14% | +18.0% |
| Q4 2018 | $251,000 | +4.1% | 28,700 | -8.9% | 0.12% | -5.4% |
| Q3 2018 | $241,000 | +54.5% | 31,500 | -3.1% | 0.13% | +81.7% |
| Q2 2018 | $156,000 | -50.0% | 32,500 | -50.0% | 0.07% | -22.8% |
| Q1 2018 | $312,000 | +90.2% | 65,000 | +94.0% | 0.09% | +19.5% |
| Q4 2017 | $164,000 | – | 33,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
| MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
| Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
| Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
| Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
| Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
| Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
| Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |